323 related articles for article (PubMed ID: 27863278)
1. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
[TBL] [Abstract][Full Text] [Related]
2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
3. Early add-on lacosamide in a real-life setting: results of the REALLY study.
Villanueva V; Garcés M; López-Gomáriz E; Serratosa JM; González-Giráldez B; Parra J; Rodríguez-Uranga J; Toledo M; López González FJ; Bermejo P; Giner P; Castillo A; Molins A; Campos D; Mauri JÁ; Muñoz R; Bonet M; Serrano-Castro P; del Villar A; Saiz-Díaz RA;
Clin Drug Investig; 2015 Feb; 35(2):121-31. PubMed ID: 25488477
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
[TBL] [Abstract][Full Text] [Related]
5. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.
Maschio M; Dinapoli L; Mingoia M; Sperati F; Pace A; Pompili A; Carapella CM; Vidiri A; Muti P
J Neurol; 2011 Nov; 258(11):2100-4. PubMed ID: 21674196
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
7. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
[TBL] [Abstract][Full Text] [Related]
10. Outcome of cancer-related seizures in patients treated with lacosamide.
Toledo M; Molins A; Quintana M; Santamarina E; Martinez-Ricarte F; Martínez-Saez E; Salas-Puig J
Acta Neurol Scand; 2018 Jan; 137(1):67-75. PubMed ID: 28832891
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study.
Kalilani L; Lu C; Pierre-Louis B; Gold M
Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
[TBL] [Abstract][Full Text] [Related]
13. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
[TBL] [Abstract][Full Text] [Related]
15. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide monotherapy for partial onset seizures.
Lattanzi S; Cagnetti C; Foschi N; Provinciali L; Silvestrini M
Seizure; 2015 Apr; 27():71-4. PubMed ID: 25891931
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
Sanmartí-Vilaplana F; Díaz-Gómez A
Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
